[Distribution of values of glycated haemoglobin in a population with type 2 diabetes: a project Valetudo]

Related Experiment Video

Updated: Oct 12, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Milan Kvapil

    Vnitrni Lekarstvi
    |February 20, 2015
    PubMed

    Insights

    This study analyzed glycated haemoglobin (HbA1c) levels in Czech type 2 diabetes patients. Results show an average frequency of 1.88% per mmol/mol within the 43-80 mmol/mol range, informing treatment guidelines.

    Area of Science:

    • Endocrinology
    • Metabolic Diseases
    • Clinical Research

    Background:

    • Limited data exists on glycated haemoglobin (HbA1c) distribution in Czech type 2 diabetes patients.
    • Current reimbursement criteria for new antidiabetic agents in the Czech Republic are based on a poorly compensated diabetes threshold of 60 mmol/mol (6% IFCC).
    • This threshold may restrict access to effective therapies for a significant patient population.

    Purpose of the Study:

    • To analyze the distribution of glycated haemoglobin (HbA1c) values in a random population of patients with type 2 diabetes in the Czech Republic.
    • To provide data that can inform the interpretation of HbA1c levels and potentially influence treatment guidelines and reimbursement policies.
    • To understand the prevalence of different HbA1c levels within critical ranges relevant to diabetes management.

    Main Methods:

    • The Valetudo project conducted a cross-sectional study.
    • Data on glycated haemoglobin (HbA1c) values were collected from a random sample of type 2 diabetes patients.
    • Statistical analysis was performed to determine the frequency distribution of HbA1c values.

    Main Results:

    • The study found that within the critical HbA1c range of 43 mmol/mol to 80 mmol/mol, the average frequency of patients was 1.88% per 1 mmol/mol.
    • This indicates a substantial number of patients fall within or near the threshold for poorly compensated diabetes.
    • Interpreting these cross-sectional data is complex due to the inclusion of patients at various stages of treatment.

    Conclusions:

    • The distribution of glycated haemoglobin (HbA1c) values in Czech type 2 diabetes patients has been characterized.
    • The findings highlight the need for a nuanced understanding of HbA1c distribution to guide clinical practice and policy.
    • Further research is needed to interpret these findings in the context of treatment efficacy and patient outcomes.

    Related Concept Videos

    Carbohydrate Metabolism01:36

    Carbohydrate Metabolism

    Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
    Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
    15.2K
    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    6.4K
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    5.9K
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
    4.6K
    Diabetes: Symptoms, Diagnosis, and Complications01:15

    Diabetes: Symptoms, Diagnosis, and Complications

    For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
    2.9K
    Diabetes: Management and Pharmacotherapy01:15

    Diabetes: Management and Pharmacotherapy

    The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
    Insulin remains the cornerstone of treatment for most patients with type 1 and many...
    1.5K